Home Bioscience eyes fresh funds

The European company builder Home Biosciences is in the process of raising its second financing round, with $40m targeted. The cash will be used to support four start-ups, two of which have already been announced with a further two hopefully emerging by year end, chief executive David Schilansky tells Evaluate Vantage.